SCHEMBL8320378

SCHEMBL8320378

CC(CC(=O)OC1CCCC1)C(=O)COc1c(F)c(F)cc(F)c1F

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 15/20 0.52
▸ CTSV O60911 1/20 0.47
▸ CTSL P07711 1/20 0.47
▸ CTSB P07858 1/20 0.47
▸ CTSH P09668 1/20 0.47
▸ CTSS P25774 1/20 0.47
▸ CTSK P43235 1/20 0.47
▸ CTSF Q9UBX1 1/20 0.47
▸ MAPK1 P28482 1/20 0.46
▸ CASP6 P55212 4/20 0.42
▸ CASP8 Q14790 4/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20827198 0.78 CASP3 (0.55) CASP3CASP6CASP8CASP7KDM4E
SCHEMBL20827298 0.74 CASP3 (0.44) CASP3CASP6CASP8CASP7KDM4E
SCHEMBL22307837 0.73 KDM4E (0.55) CASP3CTSVCTSLCTSBCTSH
SCHEMBL25985226 0.70 KDM4E (0.52) CASP3CTSVCTSLCTSBCTSH
SCHEMBL24710324 0.70 CASP3 (0.41) CASP3CTSVCTSLCTSBCTSH
SCHEMBL22308314 0.69 KDM4E (0.45) CASP3CTSVCTSLCTSBCTSH
SCHEMBL8980141 0.68 CYP2C19 (0.50) HTT
SCHEMBL22307313 0.68 MAPT (0.56) CASP3MAPK1CASP6CASP8CASP7
SCHEMBL8980116 0.67 CYP2C19 (0.53) MAPK1KDM4EALDH1A1HTT
SCHEMBL1999871 0.67 CYP2C19 (0.53) MAPK1KDM4EALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004058718-A1 4-OXO-3-(1-OXO-1H-ISOQUINOLIN-2-YLACETYLAMINO)-PENTANOIC ACID ESTER AND AMIDE DERIVATIVES AND THEIR USE AS CASPASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-07-15 — — WO disclosed
Send feedback